Cannabis Law Report

JULY 31, 2019

3] The CSA established five schedules of controlled substances, with Schedule I substances defined as those which have a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. [4] Health and Safety Code § 11362.5. [7] 812(b)(1). [5]

Law 40

Law Legalization Marijuana Policy 40

The Cannigma

JANUARY 13, 2023

1 A 2008 study found serotonin and endocannabinoid levels, including anandamide, were lower in people with chronic migraines. Daily cannabis consumption was an effective treatment for 85% of participants. All 3 had β-caryophyllene as 1 of the top 3 terpenes, along with a mix of linalool, limonene, β-myrcene, bisabolol, and humulene.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

SEPTEMBER 12, 2021

This contradiction, combined with a problematic regulatory framework that limits access to THC products in many states, has created a booming market for d-8 and d-10. The safety of using these products however, is still unknown. The first researcher who identified and isolated THC, was the American Roger Adams (Shutterstock).

THC 98

THC Research and Development Cannabinoids CBD 98

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

DECEMBER 8, 2021

By sufficiently moving the needle on public opinion, NORML aims to legalize the responsible use of marijuana by adults, and subsequently ensure access to products that are safe, convenient, and affordable. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca. Let’s have a listen.

Access 81

Access Policy Patients Cannabis 81

SpeedWeed

JULY 30, 2021

Consequently, it is difficult to draw conclusions about the potential effects of marijuana legalization and commercialization on public safety, public health, or youth outcomes, and this may always be the case due to the lack of historical data. High school students’ perception of easy access to cannabis decreased: 57.2% Public Safety.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Consequently, it is difficult to draw conclusions about the potential effects of marijuana legalization and commercialization on public safety, public health, or youth outcomes, and this may always be the case due to the lack of historical data. High school students’ perception of easy access to cannabis decreased: 57.2% Public Safety.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Consequently, it is difficult to draw conclusions about the potential effects of marijuana legalization and commercialization on public safety, public health, or youth outcomes, and this may always be the case due to the lack of historical data. High school students’ perception of easy access to cannabis decreased: 57.2% Public Safety.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Consequently, it is difficult to draw conclusions about the potential effects of marijuana legalization and commercialization on public safety, public health, or youth outcomes, and this may always be the case due to the lack of historical data. High school students’ perception of easy access to cannabis decreased: 57.2% Public Safety.

Data 52

Data Safety Cannabinoids Cannabis 52

SpeedWeed

JULY 30, 2021

Consequently, it is difficult to draw conclusions about the potential effects of marijuana legalization and commercialization on public safety, public health, or youth outcomes, and this may always be the case due to the lack of historical data. High school students’ perception of easy access to cannabis decreased: 57.2% Public Safety.

Dispensary 52

Dispensary Data Safety Cannabinoids 52

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. An advocate for the appropriate use of consciousness-expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication. in/julie-holland-b1a7a13/ [link].

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JANUARY 21, 2019

Track-and-Trace System Reporting Requirements, Section 40513 Track-and-Trace – Loss of Access, Section 40515 Track-and-Trace Temporary Licenses, and Section 40517 Track-and-Trace System – UID Tag Order. All electronic storage systems must provide a complete and accurate record of your data that is accessible to the IRS. .

Seed-To-Sale 40

Seed-To-Sale Business Compliance Compliance 40